but should not drop to <80-90 mmHg. A longer therapy may be beneficial for patients with recurrent chest pain or persistent pulmonary congestion. Nitroglycerin in the first few hours reduces infarct size in high risk patients and in the short term and possibly long term reduces the risk of mortality. Nitroglycerin is not used routinely in patients with uncomplicated myocardial infarction, and a low risk. Fibrinolytics tenecteplase (TNK)

Alteplase (rTPA)

Reteplase (rPA)

Streptokinase and anistreplase (APSAC

Health Life Media Team

Leave a Reply